Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment
Abstract Background Hepatocellular carcinoma (HCC) is the third most common cause of cancer death worldwide, with an overall 5-year survival rate of less than 18%, which may be related to tumor microvascular invasion (MVI). This study aimed to compare the clinical prognosis of HCC patients with or w...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-022-02792-y |
_version_ | 1828167439772286976 |
---|---|
author | Yuling Xiong Peng Cao Xiaohua Lei Weiping Tang Chengming Ding Shuo Qi Guodong Chen |
author_facet | Yuling Xiong Peng Cao Xiaohua Lei Weiping Tang Chengming Ding Shuo Qi Guodong Chen |
author_sort | Yuling Xiong |
collection | DOAJ |
description | Abstract Background Hepatocellular carcinoma (HCC) is the third most common cause of cancer death worldwide, with an overall 5-year survival rate of less than 18%, which may be related to tumor microvascular invasion (MVI). This study aimed to compare the clinical prognosis of HCC patients with or without MVI after radical surgical treatment, and further analyze the preoperative risk factors related to MVI to promote the development of a new treatment strategy for HCC. Methods According to the postoperative pathological diagnosis of MVI, 160 study patients undergoing radical hepatectomy were divided into an MVI-negative group (n = 68) and an MVI-positive group (n = 92). The clinical outcomes and prognosis were compared between the two groups, and then the parameters were analyzed by multivariate logistic regression to construct an MVI prediction model. Then, the practicability and validity of the model were evaluated, and the clinical prognosis of different MVI risk groups was subsequently compared. Result There were no significant differences between the MVI-negative and MVI-positive groups in clinical baseline, hematological, or imaging data. Additionally, the clinical outcome comparison between the two groups presented no significant differences except for the pathological grading (P = 0.002) and survival and recurrence rates after surgery (P < 0.001). The MVI prediction model, based on preoperative AFP, tumor diameter, and TNM stage, presented superior predictive efficacy (AUC = 0.7997) and good practicability (high H-L goodness of fit, P = 0.231). Compared with the MVI high-risk group, the patients in the MVI low-risk group had a higher survival rate (P = 0.002) and a lower recurrence rate (P = 0.004). Conclusion MVI is an independent risk factor for a poor prognosis after radical resection of HCC. The MVI prediction model, consisting of AFP, tumor diameter, and TNM stage, exhibits superior predictive efficacy and strong clinical practicability for MVI prediction and prognostication, which provides a new therapeutic strategy for the standardized treatment of HCC patients. |
first_indexed | 2024-04-12T02:17:59Z |
format | Article |
id | doaj.art-607ea9860c7e4263b0856e947293887b |
institution | Directory Open Access Journal |
issn | 1477-7819 |
language | English |
last_indexed | 2024-04-12T02:17:59Z |
publishDate | 2022-09-01 |
publisher | BMC |
record_format | Article |
series | World Journal of Surgical Oncology |
spelling | doaj.art-607ea9860c7e4263b0856e947293887b2022-12-22T03:52:12ZengBMCWorld Journal of Surgical Oncology1477-78192022-09-0120111010.1186/s12957-022-02792-yAccurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatmentYuling Xiong0Peng Cao1Xiaohua Lei2Weiping Tang3Chengming Ding4Shuo Qi5Guodong Chen6Hengyang Medical School, University of South ChinaDepartment of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South ChinaDepartment of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South ChinaDepartment of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South ChinaDepartment of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South ChinaHengyang Medical School, University of South ChinaHengyang Medical School, University of South ChinaAbstract Background Hepatocellular carcinoma (HCC) is the third most common cause of cancer death worldwide, with an overall 5-year survival rate of less than 18%, which may be related to tumor microvascular invasion (MVI). This study aimed to compare the clinical prognosis of HCC patients with or without MVI after radical surgical treatment, and further analyze the preoperative risk factors related to MVI to promote the development of a new treatment strategy for HCC. Methods According to the postoperative pathological diagnosis of MVI, 160 study patients undergoing radical hepatectomy were divided into an MVI-negative group (n = 68) and an MVI-positive group (n = 92). The clinical outcomes and prognosis were compared between the two groups, and then the parameters were analyzed by multivariate logistic regression to construct an MVI prediction model. Then, the practicability and validity of the model were evaluated, and the clinical prognosis of different MVI risk groups was subsequently compared. Result There were no significant differences between the MVI-negative and MVI-positive groups in clinical baseline, hematological, or imaging data. Additionally, the clinical outcome comparison between the two groups presented no significant differences except for the pathological grading (P = 0.002) and survival and recurrence rates after surgery (P < 0.001). The MVI prediction model, based on preoperative AFP, tumor diameter, and TNM stage, presented superior predictive efficacy (AUC = 0.7997) and good practicability (high H-L goodness of fit, P = 0.231). Compared with the MVI high-risk group, the patients in the MVI low-risk group had a higher survival rate (P = 0.002) and a lower recurrence rate (P = 0.004). Conclusion MVI is an independent risk factor for a poor prognosis after radical resection of HCC. The MVI prediction model, consisting of AFP, tumor diameter, and TNM stage, exhibits superior predictive efficacy and strong clinical practicability for MVI prediction and prognostication, which provides a new therapeutic strategy for the standardized treatment of HCC patients.https://doi.org/10.1186/s12957-022-02792-yMicrovascular invasionHepatocellular carcinomaSurvival analysisPrediction modelTherapeutic strategy |
spellingShingle | Yuling Xiong Peng Cao Xiaohua Lei Weiping Tang Chengming Ding Shuo Qi Guodong Chen Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment World Journal of Surgical Oncology Microvascular invasion Hepatocellular carcinoma Survival analysis Prediction model Therapeutic strategy |
title | Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment |
title_full | Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment |
title_fullStr | Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment |
title_full_unstemmed | Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment |
title_short | Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment |
title_sort | accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment |
topic | Microvascular invasion Hepatocellular carcinoma Survival analysis Prediction model Therapeutic strategy |
url | https://doi.org/10.1186/s12957-022-02792-y |
work_keys_str_mv | AT yulingxiong accuratepredictionofmicrovascularinvasionoccurrenceandeffectiveprognosticestimationforpatientswithhepatocellularcarcinomaafterradicalsurgicaltreatment AT pengcao accuratepredictionofmicrovascularinvasionoccurrenceandeffectiveprognosticestimationforpatientswithhepatocellularcarcinomaafterradicalsurgicaltreatment AT xiaohualei accuratepredictionofmicrovascularinvasionoccurrenceandeffectiveprognosticestimationforpatientswithhepatocellularcarcinomaafterradicalsurgicaltreatment AT weipingtang accuratepredictionofmicrovascularinvasionoccurrenceandeffectiveprognosticestimationforpatientswithhepatocellularcarcinomaafterradicalsurgicaltreatment AT chengmingding accuratepredictionofmicrovascularinvasionoccurrenceandeffectiveprognosticestimationforpatientswithhepatocellularcarcinomaafterradicalsurgicaltreatment AT shuoqi accuratepredictionofmicrovascularinvasionoccurrenceandeffectiveprognosticestimationforpatientswithhepatocellularcarcinomaafterradicalsurgicaltreatment AT guodongchen accuratepredictionofmicrovascularinvasionoccurrenceandeffectiveprognosticestimationforpatientswithhepatocellularcarcinomaafterradicalsurgicaltreatment |